-+ 0.00%
-+ 0.00%
-+ 0.00%

ERASCA SHARES DOWN 19.2% PREMARKET AFTER EARLY STAGE TRIAL RESULTS FOR EXPERIMENTAL CANCER DRUG

Reuters·11/20/2026 12:16:57

Please log in to view news